Please provide your email address to receive an email when new articles are posted on . “In patients with [isocitrate dehydrogenase (IDH)] wild-type glioblastoma, epileptic seizures are common during ...
CHICAGO – Mar. 20, 2003 – New data shows that the antiepileptic drug Keppra (levetiracetam), when used alone and in combination with other treatments, provided relief to more than 90 percent of ...
Am J Health Syst Pharm. 2009;66(6):541-561. Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam ...
NEW YORK (Reuters Health) - Treatment with low doses of levetiracetam, the active ingredient in the drug Keppra, appears to be effective by itself for controlling newly diagnosed epilepsy, new ...
UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR™ (levetiracetam) extended-release tablets comparing tolerability vs. levetiracetam immediate release ...
In many children with epilepsy, seizure control is inadequate or associated with intolerable side effects. There is therefore a need for new antiepileptic drugs for this patient population. This ...
Levetiracetam 100mg/mL; grape flavor; dye-free. Swallow tabs whole. Partial onset: ≥16yrs: initially 500mg twice daily. May increase at 2-week intervals in increments of 1g/day; max 3g/day. Myoclonic: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback